Wingcopter GmbH, founded in 2014 and based in Darmstadt, Germany, specializes in the development and manufacture of unmanned electric vertical takeoff and landing (eVTOL) fixed-wing aircraft. The company focuses on delivering goods such as medicines, vaccines, and food to remote health facilities and private households. Wingcopter's drones are distinguished by their patented tilt-rotor mechanism, which allows them to combine the vertical takeoff capabilities of multicopters with the long-range efficiency of fixed-wing aircraft, achieving distances of up to 75 miles and speeds of 150 mph. These drones can operate in challenging weather conditions and are also utilized for inspecting public infrastructure and long-range mapping. Wingcopter aims to improve lives through its innovative technology, serving sectors such as healthcare, agriculture, and forestry. In 2020, the company was recognized as a Technology Pioneer by the World Economic Forum.
Evotec is a global drug discovery partnership firm that collaborates with pharmaceutical and biotechnology companies, academic institutions, and nonprofit organizations to advance innovative therapeutic solutions. The company specializes in various therapeutic areas, including neuroscience, diabetes, oncology, infectious diseases, and pain and inflammation. It offers a range of services such as fee-for-service drug discovery, integrated collaborations, and development partnerships, with a significant portion of its revenue generated from shared research and development activities. Evotec has established numerous long-term alliances with major industry players and is actively involved in both clinical and pre-clinical development programs. The company also operates a segment focused on biologics, providing contract development and manufacturing organization services. Through its expertise and advanced technologies, Evotec aims to deliver differentiated therapeutics and drive the progress of drug development across multiple fields.
Blickfeld GmbH manufactures light detection and ranging (LiDAR) sensors. Its product helps to survey near-infrared light to detect the shape of objects, allowing autonomous vehicles to see, and analyze the world around them. The company also develops object detection and mapping software which measures the data provided by the sensors and helps in city planning, connected mobility, real-time mapping, and usage pattern analysis. The company caters to automotive, transportation, industrial, and robotics sectors. The company was founded in 2016 and is based in Munich, Germany.
The company Quantum Systems GmbH was founded in January 2015 and is specialized in the development and production of autonomous transition aircrafts for civilian use. Their products combine reach and efficiency with the ability to vertically take off and land without additional equipment. By means of the founding team’s diversity, Quantum-Systems manages to combine extensive experience and expertise from all relevant areas of unmanned aerial systems. In 2008 we started to conduct research in the field of autonomous flight systems and already in 2012 successfully completed the first autonomous transition. Quantum Systems GmbH is self-financed and managed by its owner. Thus, we are completely independent in our decision making.The combination of innovative power and uncompromising focus on quality make us the first choice in the area of transition flight.
InstaFreight is a digital forwarding company for B2B customers, that enables fast and uncomplicated processing of freight transports. Their goal is to become Europe's leading B2B online freight forwarding company. They stand for reliability, quality, efficiency and transparency. By offering innovative solutions and providing first-class service, they reduce the complexity of the supply chain and ensure absolute transparency for their customers and carriers.
DyeMansion GmbH, founded in 2013 and based in Munich, Germany, specializes in the post-processing and coloring of 3D-printed laser sintered parts. The company provides high-volume finishing systems that streamline the transition from raw 3D-printed components to high-value consumer and industrial products. With a focus on precision coloring and finishing, DyeMansion serves over four hundred clients, including prominent global manufacturers across various sectors such as eyewear, automotive, retail, medical, and sports equipment. The company has established itself as a leader in additive manufacturing finishing systems for polymer parts, collaborating with major industrial 3D printing systems like EOS, HP, 3D Systems, and Prodways. DyeMansion's technology enables the production of items ranging from luxury sunglasses to essential automotive components, ensuring high-quality results tailored to customer specifications.
The company Quantum Systems GmbH was founded in January 2015 and is specialized in the development and production of autonomous transition aircrafts for civilian use. Their products combine reach and efficiency with the ability to vertically take off and land without additional equipment. By means of the founding team’s diversity, Quantum-Systems manages to combine extensive experience and expertise from all relevant areas of unmanned aerial systems. In 2008 we started to conduct research in the field of autonomous flight systems and already in 2012 successfully completed the first autonomous transition. Quantum Systems GmbH is self-financed and managed by its owner. Thus, we are completely independent in our decision making.The combination of innovative power and uncompromising focus on quality make us the first choice in the area of transition flight.
IDnow is a technology company based in Munich, Germany, specializing in identity verification services through its Identity-as-a-Service platform. Established in 2014, the company employs advanced machine-learning technology to provide real-time identity verification that ensures legal security across Europe and maintains high data security standards. IDnow's solutions enable businesses to conduct customer identification and contract signings online without the need for additional hardware, making it particularly appealing to sectors such as banking, telecommunications, and fintech. The company's clientele includes notable firms like Commerzbank, UBS, Sixt neuwagen, Telefónica, and N26, highlighting its reputation in the industry.
• Bizay has empowered more than 1 Million SMB’s to grow their businesses during the last 5 years. • Bizay is a tech-based B2B Marketplace for made-to-order products. Running a fabless business model (no capex), it leverages on the idle capacity of production partners to meet the needs of the SMB’s. • Started on printing, packaging, textile and professional products and now applying the same model in furniture, food and 3D printing (amongst others). • 360imprimir / 360onlineprint - rebranded to Bizay - Your bussiness your way - to reflect the unlimited product categories. • Bizay is the customer facing brand (the SMB’s do not meet the production partners) and its tech platform manages the production by: o Using data and algorithms to aggregate different orders and to decide in which suppliers to produce them, driving huge efficiency and speed gains. o Enabling full tracking of the orders in the different production partners and automating pre-production processes. • Bizay differentiates themselves from other players by offering: o Online configuration of the products (options to customize and personalize). o Competitive pricing for small and medium orders (similar price per unit as for large orders), 48 hours of delivery time (instead of several weeks) and guaranteed quality (customer-facing brand ensuring high quality levels). o Integrated value chain in a single offer (on-demand design services provided by external providers). • Originally selling in Portugal, Spain, Brazil and México, the company raised B round of 18m€ one year ago (communicated in April) in order to launch new countries. • 17 new countries were launched in 2019 simultaneously (including DE, FR, UK and USA). • In 2019, 8 months of trading in the new countries confirm: o Competitiveness pricing of their offer in all the market. o Market deepness and sound acquisition metrics.
The Internet of Things (IoT) is a global major trend. It promises a future in which people and processes communicate and interact with each other fully automatically, almost as if controlled by magic. But to achieve this, we need to know the exact location and status of all relevant “things.” We need to connect these things. And this requires a real-time intelligence that lets everything communicate as quickly and intelligently as possible. That’s exactly what we at KINEXON do. For this purpose we offer real-time location solutions and and open edge computing platforms.
Magazino GmbH is a German company specializing in the development and manufacturing of mobile robots tailored for the storage and intralogistics sectors. Established in 2014 and based in Munich, Magazino produces perception-controlled robots capable of identifying, grasping, and precisely placing individual items from shelves, primarily for e-commerce applications. Their innovative approach incorporates a sophisticated operating system known as ACROS, which allows robots to receive tasks and updates, and an application for monitoring robot performance. The company aims to enhance automation in various industries, including mail-order, warehousing, production lines, and pharmacies, with the vision of creating self-thinking and self-acting warehouses. Magazino's technology not only improves operational efficiency but also contributes to the broader evolution of robotics in logistics.
NavVis GmbH specializes in indoor spatial intelligence solutions for enterprises, offering advanced tools for mapping and visualizing indoor environments. The company develops the NavVis M6, a mobile mapping system designed for large-scale scanning projects, which captures immersive 360° imagery and point clouds. Its NavVis IndoorViewer integrates these point clouds with detailed images to create digital twins, allowing stakeholders to interact with scanned spaces. The company also provides a software development kit to enhance its offerings. NavVis's solutions support various applications, including CAD/BIM modeling, factory planning, maintenance, and indoor navigation. Its client base includes prominent firms in the automotive, construction, real estate, and insurance sectors. Founded in 2013 and headquartered in Munich, Germany, NavVis also maintains offices in New York and Shanghai.
CureVac is a clinical-stage biopharmaceutical company that provides prophylactic and therapeutic application of messenger RNA. The company develops drugs that are based on Messenger RNA (mRNA) as a data carrier to instruct the human body to produce its own proteins capable of fighting a wide range of diseases.
mRNA programs include novel mRNA-based cancer immunotherapies and prophylactic vaccines against infectious diseases (RNActive), molecular therapies designed to trigger the body’s own production of therapeutic proteins (RNArt), and RNA encoded antibodies (RNAntibody). Its most advanced product candidate, CV9104, is being developed in Phase IIb for the treatment of prostate cancer.
BioNTech is a biotechnology company focused on developing and commercializing immunotherapies for cancer and infectious diseases. Founded in 2008 and headquartered in Mainz, Germany, the company has pioneered innovative therapies through advanced computational discovery and drug development platforms. BioNTech's oncology pipeline includes various neoantigen-targeted therapies, such as NEO-PV-01 for advanced non-small cell lung cancer and multiple FixVac product candidates for different cancers, including melanoma, prostate cancer, and HPV-positive head and neck cancers. The company also explores mRNA vaccine candidates for infectious diseases and maintains collaborations with prominent pharmaceutical firms. BioNTech Cell & Gene Therapies GmbH, a subsidiary, specializes in developing T cell immunotherapies for cancer treatment.
Voxeljet AG is a manufacturer of industrial 3D printing systems and a provider of on-demand parts services, catering to a diverse clientele across Europe, the Middle East, Africa, Asia Pacific, and the Americas. The company operates in two main segments: Systems and Services. The Systems segment focuses on the development and production of high-speed, large-format 3D printers, offering a range that includes models suited for various applications. The Services segment specializes in creating custom parts, sand molds, and plastic models using 3D computer-aided design, primarily for industries such as automotive, aerospace, engineering, and arts. Voxeljet operates one of Europe's largest service centers for on-demand production, enabling customers to efficiently manufacture small batches and prototypes without traditional tooling. Founded in 1999 and headquartered in Friedberg, Germany, Voxeljet serves a wide array of clients, including automotive manufacturers, foundries, and research institutions.
ITM Isotopen Technologien München AG is a biotechnology and radiopharmaceutical company based in Garching, Germany, founded in 2004. The company specializes in the development, production, and global supply of targeted diagnostic and therapeutic radiopharmaceuticals and radionuclides for cancer treatment. ITM offers a range of products, including EndolucinBeta, a radiopharmaceutical precursor for nuclear medicine, and radionuclides like 225Ac and 213Bi for next-generation targeted therapies. Additionally, it provides automated systems for the preparation of radiolabeled biomolecules and various GMP radiolabeling services. ITM is actively developing a portfolio of treatments aimed at various cancers, including neuroendocrine tumors and bone metastases, with a focus on improving patient outcomes and quality of life while minimizing side effects. The company has established a robust global supply network and has received marketing authorization for some of its products, marking significant progress in its mission to advance targeted radionuclide therapies in precision oncology.
Telefónica Deutschland offers mobile and fixed services for private and business customers, as well as innovative digital products and services in the fields of Internet of Things and data analytics. With a total of 49.6 million1) customer lines, the company is one of the leading integrated telecommunications providers. In the mobile segment alone, Telefónica Deutschland is responsible for more than 45 million1) lines. Telefónica Deutschland will become the "Mobile Customer & Digital Champion" – with this aspiration, the company intends to become the preferred customer partner in the German mobile service market by 2022. This is linked to a clear mandate that Telefónica Deutschland will make its customers’ lives easier and better and allows them mobile freedom in the digital world. In concrete terms, this means a consistently positive experience with the brand, products, customer service and network. The company already has an excellent foundation to reach this goal. No network operator in Germany connects more people with mobile services. Following the integration of E-Plus, the company is digitalising its business model while consistently focusing on customer benefit.
BioNTech is a biotechnology company focused on developing and commercializing immunotherapies for cancer and infectious diseases. Founded in 2008 and headquartered in Mainz, Germany, the company has pioneered innovative therapies through advanced computational discovery and drug development platforms. BioNTech's oncology pipeline includes various neoantigen-targeted therapies, such as NEO-PV-01 for advanced non-small cell lung cancer and multiple FixVac product candidates for different cancers, including melanoma, prostate cancer, and HPV-positive head and neck cancers. The company also explores mRNA vaccine candidates for infectious diseases and maintains collaborations with prominent pharmaceutical firms. BioNTech Cell & Gene Therapies GmbH, a subsidiary, specializes in developing T cell immunotherapies for cancer treatment.
Ottobock has stood for innovation and entrepreneurial success, combined with the calling to provide handicapped people with the best possible quality of life through freedom of movement and independence. Driven by a pioneering spirit, courage and decisiveness,
FAZUA specializes in developing an e-Bike drive system. Its e-Bike drive system was designed to meet sportive demands and, at the same time to create a natural feeling of non-motorized bike riding.
FAZUA was founded in 2013 and is headquartered in Ottobrunn, Bayern, Germany.
FlixMobility operates FlixBus and FlixTrain, providing convenient, affordable, and environmentally-friendly travel options across Europe and the United States. Since its inception, the company has developed Europe’s largest long-distance bus network and introduced the first green long-distance trains in 2018. FlixMobility employs a unique business model that leverages technology and partnerships with regional bus operators and private train companies, allowing it to offer high-quality services while maintaining sustainability. The platform features amenities such as free WiFi, innovative ticketing systems, and flexible online booking, catering to diverse budgets and travel needs. With over 100 million travelers served since 2013, FlixMobility has significantly impacted the mobility landscape, creating thousands of jobs and promoting greener travel alternatives.
Curetis N.V. is a commercial-stage molecular diagnostics company based in Holzgerlingen, Germany, specializing in solutions for severe infectious diseases. The company develops and manufactures a range of molecular microbiology products aimed at detecting various pathogens, including bacteria and fungi, as well as identifying genetic markers for antimicrobial resistance. Key offerings include the Unyvero L4 Lysator for sample pre-processing, the Unyvero A50 Analyzer, and the Unyvero C8 Cockpit, which serves as a control panel for these devices. Curetis also provides Unyvero Application Cartridges for syndromic infectious disease testing and the ARES AMR Database, which compiles data on antimicrobial resistance genetics. Its tests cover multiple infections, including pneumonia and urinary tract infections. Founded in 2007, Curetis has established strategic partnerships with companies like MGI Tech Co. Ltd. and Qiagen N.V., enhancing its capabilities in the molecular diagnostics market.
Aerogen Limited, a medical device and drug delivery company, engages in the design, manufacture, and marketing of aerosol drug delivery systems. It offers Aerogen Solo, a compact and single patient use nebulizer for aerosol therapy; Aerogen Ultra, a solution for spontaneous breathing patients; Aerogen Pro, a nebulizer for treating mechanically ventilated patients; Aerogen Go, a nebulizer enabling people to build their nebulizer treatments; Aerogen Lab, a nebulizer for use in preclinical aerosol research and inhalation studies; Aerogen Pro-X Controller, portable power source for Aerogen Solo; Aerogen USB controller, power source for Aerogen Solo; Aerogen nebulization, a tube set for continuous nebulization and precise medication control of patients, and Vibronic, a high performance aerosol technology. The company sells its products through a network of distributors worldwide. Aerogen Limited was formerly known as Aerogen (Ireland) Ltd. and changed its name to Aerogen Limited in December 2007. The company was founded in 1997 and is based in Galway, Ireland with additional offices in Chicago, Illinois; Ratingen, Germany; Fengtai District, China; Dubai, United Arab Emirates; and New Delhi, Delhi.
MotorK is an Italian software company founded in 2010, specializing in cloud-based solutions for the automotive industry. With a workforce of 330 employees and subsidiaries in the UK, France, Spain, and Germany, MotorK provides a range of integrated digital products and services aimed at helping automotive manufacturers and dealers adapt to the digital landscape. The company offers various platforms, including DriveK, targeted at original equipment manufacturers, and DealerK, tailored for auto dealers. In addition, MotorK provides Internet Motors, which focuses on digital training and events for the automotive sector. Its offerings encompass tools for traffic acquisition, inventory management, sales operations, and promotional campaigns, enabling clients to enhance their online visibility and streamline their sales processes in a competitive marketplace.
tado° GmbH is a Munich-based company that specializes in developing home climate control systems aimed at enhancing the efficiency of heating and cooling in residential and small business settings. Founded in 2010, tado° offers a combination of hardware and software solutions that intelligently adjust climate controls based on residents' behaviors, current weather conditions, and specific building characteristics. The company's products are available through various retail outlets and online platforms. With a focus on integrating Internet of Things technology into the Cleantech sector, tado° aims to provide innovative solutions for energy-efficient climate management. The company also has an office in London, expanding its reach in the market.
Jennewein Biotechnologie GmbH, established in 2005 and located in Rheinbreitbach, Germany, specializes in the production of functional sugars, particularly human milk oligosaccharides (HMOs) and rare monosaccharides. As a subsidiary of Chr. Hansen Holding A/S, the company focuses on innovative processes for identifying, characterizing, and manufacturing these complex sugar molecules, which are primarily utilized in the food, pharmaceutical, and cosmetic industries. HMOs, found uniquely in human milk, offer significant health benefits without providing calories, making them valuable as food ingredients, especially in infant milk formulas. Jennewein Biotechnologie has developed a diverse portfolio of HMO products, including 2' fucosyllactose and Lacto-N-neotetraose, and has expanded its production capacity to meet growing demand in various sectors.
Indivumed was founded in Hamburg, Germany in 2002 with one main driver – the individualization of cancer therapy through the generation, characterization, and analysis of biologic samples from human cancer patients. Since then, the company has expanded globally, with a subsidiary in the USA, partnerships with leading cancer clinics in Europe, the US and Asia and more than 50 oncology practices located in Germany, and, finally, more than 100 biopharma industry partners – and a global reputation for product and service quality.
Arzneimittelwerk Warngau is a pharmaceutical company based in Warngau, Germany, specializing in the development and manufacturing of innovative drug delivery systems. Founded in 2008 by Wilfried Fischer, the company focuses on creating therapeutic solutions primarily in the fields of oncology, pain therapy, and neurology. Its product portfolio includes active ingredient and biodegradable implants, as well as transdermal systems, featuring both passive and microchip-controlled patches. Through its commitment to advancing drug delivery technologies, Arzneimittelwerk Warngau aims to improve patient outcomes in various therapeutic areas.
Censhare, originally founded as CoWare AG in 2001, has evolved into a prominent player in the digital communication space, particularly after its partnership with DuMont in 2017. The company, which is headquartered in Munich, Germany, employs nearly 300 professionals and offers solutions to clients worldwide. Censhare's platform addresses various content challenges faced by organizations across different industries, including web content management, digital asset management, and product information management. This enables clients to efficiently manage their content while reaching diverse global audiences through multiple channels and languages. As businesses increasingly embrace content marketing and seek to establish their own media channels, Censhare provides the tools necessary for content monetization and operational efficiency, making it an essential partner for brands navigating the digital landscape.
EGYM specializes in enhancing the gym experience for operators, trainers, and members through innovative technology solutions. The company provides a cloud platform that connects various training hardware, allowing for seamless data access via its Trainer and Member Apps. EGYM has also developed smart strength machines that integrate with this cloud system, promoting a more efficient workout environment. By offering a B2B corporate fitness subscription solution, EGYM caters to employers and delivers personalized, data-driven fitness experiences for employees and gym users. This approach enables fitness enthusiasts to achieve their training goals, including muscle gain, performance improvement, and rehabilitation.
medneo GmbH is a German company specializing in diagnostic imaging services. It operates on a "radiology as a service" model, providing medical images to clinicians and hospitals rather than selling imaging equipment. By offering pay-per-use solutions for diagnostic image acquisition and reporting, medneo enhances operational efficiency and image quality while reducing costs. The company focuses on improving access to radiology services for patients, minimizing waiting times typically associated with such diagnostics. With its diagnostic centers and teleradiology sites, medneo aims to streamline the imaging process, benefiting both healthcare providers and patients. Based in Berlin, Germany, medneo integrates advanced technology and service-oriented solutions in the imaging diagnostics market.
Evotec is a global drug discovery partnership firm that collaborates with pharmaceutical and biotechnology companies, academic institutions, and nonprofit organizations to advance innovative therapeutic solutions. The company specializes in various therapeutic areas, including neuroscience, diabetes, oncology, infectious diseases, and pain and inflammation. It offers a range of services such as fee-for-service drug discovery, integrated collaborations, and development partnerships, with a significant portion of its revenue generated from shared research and development activities. Evotec has established numerous long-term alliances with major industry players and is actively involved in both clinical and pre-clinical development programs. The company also operates a segment focused on biologics, providing contract development and manufacturing organization services. Through its expertise and advanced technologies, Evotec aims to deliver differentiated therapeutics and drive the progress of drug development across multiple fields.
Nosto Solutions Oy specializes in e-commerce personalization solutions for online retailers worldwide. Founded in 2011 and headquartered in Helsinki, Finland, the company offers a platform-independent software-as-a-service (SaaS) solution that enables retailers to provide real-time personalized product recommendations throughout the shopping journey. Nosto's technology is designed to enhance the online shopping experience, making it accessible for businesses of all sizes. Their offerings include automated marketing tools such as onsite product recommendations, personalized emails, and targeted advertisements on platforms like Facebook and Instagram. Nosto has served notable clients, including brands like Angry Birds and Intersport, helping retailers increase conversion rates, customer retention, and overall store revenues. The company also has offices in key global markets, including New York, Los Angeles, Berlin, Stockholm, and London.
Skeleton Technologies OÜ specializes in manufacturing ultracapacitors and related systems, targeting applications in automotive, industrial, transportation, and energy sectors. Founded in 2009 and headquartered in Tallinn, Estonia, with additional facilities in Germany, the company utilizes patented curved graphene technology to produce ultracapacitors that boast superior energy density and power density compared to competitors. These advanced energy storage solutions enable industries to enhance efficiency, reduce fuel consumption, and lower carbon emissions. Skeleton Technologies serves a diverse clientele, including global engineering firms, the European Space Agency, and leading automotive manufacturers, while also providing welding services and maintaining a network of distributors worldwide.
Enevo Oy, founded in 2010 and headquartered in Espoo, Finland, specializes in waste management analytics. The company develops software that utilizes ultrasonic sonar technology to monitor fill levels in waste containers, providing valuable data to commercial clients, haulers, and municipalities. Enevo's solutions help streamline waste management operations and enhance the financial, environmental, and social impacts of waste handling. The company serves a diverse customer base, including restaurants, retailers, and commercial properties across North America and Europe, often through resellers in countries like the Netherlands, Belgium, and Norway. With a focus on innovation, Enevo offers a predictive, end-to-end solution that automates the planning and logistics of waste and recycling services. The company has secured over $34 million in private equity funding to support its technological advancements and operational processes.